Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Dina Kremsdorf"'
Autor:
Helene Strick-Marchand, Mathilde Dusséaux, Sylvie Darche, Nicholas D Huntington, Nicolas Legrand, Guillemette Masse-Ranson, Erwan Corcuff, James Ahodantin, Kees Weijer, Hergen Spits, Dina Kremsdorf, James P Di Santo
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0119820 (2015)
Hepatic infections by hepatitis B virus (HBV), hepatitis C virus (HCV) and Plasmodium parasites leading to acute or chronic diseases constitute a global health challenge. The species tropism of these hepatotropic pathogens is restricted to chimpanzee
Externí odkaz:
https://doaj.org/article/43f6a4441a0b474391a41a2586d8f6e5
Autor:
Nicolas Brezillon, Marie-Noëlle Brunelle, Hélène Massinet, Eric Giang, Céline Lamant, Lucie DaSilva, Sophie Berissi, Jacques Belghiti, Laurent Hannoun, Gherard Puerstinger, Eva Wimmer, Johan Neyts, Olivier Hantz, Patrick Soussan, Serban Morosan, Dina Kremsdorf
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e25096 (2011)
Current treatments for HBV chronic carriers using interferon alpha or nucleoside analogues are not effective in all patients and may induce the emergence of HBV resistant strains. Bay 41-4109, a member of the heteroaryldihydropyrimidine family, inhib
Externí odkaz:
https://doaj.org/article/ce3067c018d44286925e45fb1cf480f7
Autor:
Nicolas M. Brezillon, Lucie Dasilva, David L'hôte, Florence Bernex, Julie Piquet, Nadine Binart, Serban Morosan, Dina Kremsdorf
Publikováno v:
Cell Transplantation, Vol 17 (2008)
Development of the urokinase plasminogen activator/SCID (uPA/SCID) transgenic mouse model has opened new perspectives for the study of different biological mechanisms such as liver regeneration, stem cell differentiation, and human hepatic pathogens.
Externí odkaz:
https://doaj.org/article/c959a8cbc6214aca84f2a02be425f8ed
Publikováno v:
Carcinogenesis. 41:358-367
The hepatitis B virus X protein (HBx) has pleiotropic biological effects, which underlies its potential role in cell transformation. However, its involvement in hepatic fibrosis remains unclear. In this study, we wanted to clarify, in vivo, the role
Autor:
Janick Selves, Anne-Marie. Auteur du texte Cassard, Nadim Fares, Jean-Marie Peron, Hualin Wang, Ivan Bièche, Tarik Attout, Janet Hall, Philippe Merle, Patrick Soussan, Sophie Vacher, Aurélie Schnuriger, Bouchra Lekbaby, Isabelle Chemin, Dina Kremsdorf, Jérémy Augustin, Gabriel Perlemuter, Ganna Panasyuk, Brigitte Bancel
Publikováno v:
Hepatology International. 13:454-467
Trans-acting splicing factors (SF) shape the eukaryotic transcriptome by regulating alternative splicing (AS). This process is recurrently modulated in liver cancer suggesting its direct contribution to the course of liver disease. The aim of our stu
Autor:
Jules Sotty, Aurélie Schnuriger, Pierre Bablon, Bouchra Lekbaby, Jeremy Augustin, Morgane Girier-Dufournier, Lucas Langlois, Celine Dorival, Fabrice Carrat, Stanislas Pol, Helene Fontaine, Nazim Sarica, Christine Neuveut, Chantal Housset, Dina Kremsdorf, Patrick Soussan
Publikováno v:
Journal of Hepatology. 77:S297
Autor:
Jules Sotty, Aurélie Schnuriger, Dina Kremsdorf, Jérémy Augustin, Jonathan Pol, Patrick Soussan, Pierre Bablon, Bouchra Lekbaby
Publikováno v:
Gut. 70(12)
Regulation of alternative splicing is one of the most efficient mechanisms to enlarge the proteomic diversity in eukaryotic organisms. Many viruses hijack the splicing machinery following infection to accomplish their replication cycle. Regarding the
Autor:
Ivan, Quetier, Dina, Kremsdorf
Publikováno v:
Virologie (Montrouge, France). 18(4)
Hepatocellular carcinoma (HCC) is the most frequent form of liver cancer worldwide, and represents the third cause of death. While epidemiological studies have clearly established that hepatitis B virus (HBV) infection is a major risk factor for the
Autor:
Patrick Soussan, Chantal Desdouets, Dina Kremsdorf, Myriam Bou-Nader, James Ahodantin, Jérôme Mégret, Corinne Cordier
Publikováno v:
Oncogene
Oncogene, Nature Publishing Group, 2019, 38 (14), pp.2645-2657. ⟨10.1038/s41388-018-0607-3⟩
Oncogene, 2019, 38 (14), pp.2645-2657. ⟨10.1038/s41388-018-0607-3⟩
Oncogene, Nature Publishing Group, 2019, 38 (14), pp.2645-2657. ⟨10.1038/s41388-018-0607-3⟩
Oncogene, 2019, 38 (14), pp.2645-2657. ⟨10.1038/s41388-018-0607-3⟩
International audience; Hepatitis B virus X protein (HBx) contributes to Hepatitis B virus (HBV)-related liver cancer. However, its impact on hepatocyte proliferation and genomic stability remains elusive. We studied the role of HBx expression on the
Autor:
James Ahodantin, Marine Lefevre, Patrick T F Kennedy, Hualin Wang, Alexandre Boissonnas, Ivan Quetier, Veronique Fauveau, Delphine Sitterlin, Cerina Chhuon, Dina Kremsdorf, Francois Redelsperger, Aurélie Schnuriger, Samir Gourari, Nabil Debzi, Bouchra Lekbaby, Upkar S. Gill, Marion Duriez, Patrick Soussan, Chiara Guerrera, Yassmina Mandouri, Mala K. Maini
Publikováno v:
Journal of Hepatology
Journal of Hepatology, 2017, 67 (4), pp.687-699. ⟨10.1016/j.jhep.2017.05.025⟩
Journal of Hepatology, 2017, 67 (4), pp.687-699. ⟨10.1016/j.jhep.2017.05.025⟩
International audience; Background & aims: Hepatitis B virus (HBV) RNA can undergo alternative splicing, but the relevance of this post-transcriptional regulation remains elusive. The mechanism of HBV alternative splicing regulation and its impact on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7230e7998dfe1eb8aad8a2fa623b967e
https://www.hal.inserm.fr/inserm-03990705/document
https://www.hal.inserm.fr/inserm-03990705/document